Concord Biotech - About the company
Concord Biotech is a public company based in Ahmedabad (India), founded in 1984 by Sudir Vaid. It operates as a CDMO focused on manufacturing API. Concord Biotech has raised $11.3M in funding from Quadria Capital and Helix Investments. The company has 373 active competitors, including 15 funded and 91 that have exited. Its top competitors include companies like Aizant, Almac Group and Nucleus RadioPharma.
Company Details
CDMO focused on manufacturing API. The existing portfolio of products includes APIs in the immunosuppressant, antibiotic, oncology, antifungal and hypolipidemic segments and enzymes. It focuses in the research and manufacturing of fermentation-based semi-synthetic and synthesis based products. The company is a global supplier of fermentation based API’s and enzymes and they also offer services in areas such as strain improvement and contract fermentation & manufacturing. They have capabilities for manufacturing solid orals, oral liquids, and suspensions, as per global norms.
- Website
- concordbiotech.com
- Email ID
- *****@concordbiotech.com, *****@concordbiotech.com
- Phone Number
- +91 **********
- Registered Address
- 1482-86 TRASAD ROAD DHOLKA, AHMEDABAD, Gujarat, India, 387810
Key Metrics
Founded Year
1984
Location
Ahmedabad, India
Stage
Public
Total Funding
$11.3M in 2 rounds
Latest Funding Round
Investors
Ranked
1st among 373 active competitors
Annual Revenue
₹1,000+ Cr as on Mar 31, 2025
Employee Count
1,635 as on Aug 31, 2025
Investment & Acquisitions
Exit Details
Public
Legal entities associated with Concord Biotech
Concord Biotech is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Concord Biotech Limited CIN: L24230GJ1984PLC007440 , India, Active | Nov 23, 1984 | ₹1,000+ Cr (As on Mar 31, 2025) | 1635 (As on Aug 31, 2025) |
Concord Biotech's IPO details
Concord Biotech got listed on Aug 18, 2023.
Click here to take a look at Concord Biotech's IPO in detail
Sign up to download Concord Biotech's company profile
Concord Biotech's funding and investors
Concord Biotech has raised a total funding of $11.3M over 2 rounds. Its first funding round was on 2009. Its latest funding round was a PE round on Jul 05, 2016 for $*****. 2 investors participated in its latest round. Concord Biotech has 8 institutional investors and 12 angel investors.
Here is the list of recent funding rounds of Concord Biotech:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 05, 2016 | 3262799 | PE | 2502996 | 1028720 | 2260307 | 1568694 |
2009 | 9105 | Angel | 3668 | 7603 | 6201 |
Access funding benchmarks and valuations. Sign up today!View details of Concord Biotech's funding rounds and investors
Concord Biotech's founders and board of directors
Founder? Claim ProfileThe founders of Concord Biotech is Sudir Vaid.
Here are the details of Concord Biotech's key team members:
- Sudir Vaid: Founder of Concord Biotech. They serve on the board of 1 company.Contact Info: 1 email address and 1 phone number
Concord Biotech's Board of Directors
Concord Biotech's board has 8 active members. Sudir Vaid, Ravi Kapoor and Amit Varma are part of team and Utpal Hemendra Sheth, Rajeev Agrawal, Amitabh Gajendra Thakore, Bharti Khanna and Anil Katyal are independent board members.Here is the list of Concord Biotech's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 15y 4m | |
avjxvfg | Team | - | Current | 8y 9m |
mmyuiab | Team | - | Past | 7y 3m |
jpnuzku | Team | - | Past | 2y 8m |
wqpmqib | Team | - | Past | 4y 5m |
mqxilig | Independent board member | - | Past | 1y 6m |
abzzkr{ | Independent board member | - | Past | 4y 9m |
cfiguth | Independent board member | - | Past | 6y 7m |
kajsvsg | Independent board member | - | Past | 3y 8m |
obtmhhh | Independent board member | - | Past | 3y 7m |
{{tzlk{ | Independent board member | - | Past | 7y 5m |
fanfkyx | Independent board member | - | Past | 8y 5m |
mbps{yz | Independent board member | - | Past | 9y 8m |
b{ydraz | Independent board member | - | Past | 1y 5m |
qjjkigs | Independent board member | - | Past | 4y 9m |
gmkdgew | Independent board member | - | Past | 6y 9m |
ls{qexo | Independent board member | - | Past | 2y 5m |
w{xowrl | Independent board member | - | Past | 2y 4m |
{qq{poe | Independent board member | - | Past | 2y 2m |
View details of Concord Biotech's Founder profiles and Board Members
Concord Biotech's employee count trend
Concord Biotech has 1,635 employees as of Aug 25. The total employee count is 9.0% more than what it was in Aug 24. Here is Concord Biotech's employee count trend over the years:
Uncover Concord Biotech's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Concord Biotech's Competitors and alternates
Top competitors of Concord Biotech include Aizant, Almac Group and Nucleus RadioPharma. Here is the list of Top 10 competitors of Concord Biotech, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Concord Biotech 1984, Ahmedabad (India), Public | CDMO focused on manufacturing API | $11.3M | 69/100 | |
2nd | Company offering contract development services for small molecules | $16.8M | 60/100 | ||
3rd | Almac Group 2001, Craigavon (United Kingdom), Series D | CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development | $339M | 57/100 | |
4th |  Nucleus RadioPharma 2022, Rochester (United States), Series A | CDMO focused on providing of radiopharmaceuticals manufacturing and supply chain services | $72.1M | 54/100 | |
5th | Indoco Remedies 1947, Mumbai (India), Public | Provider of APIs manufacturing and formulation services | - | 54/100 | |
6th |  Wanbury Limited 1990, Mumbai (India), Public | Manufacturer of anti-diabetic drugs | - | - | 53/100 |
7th | Development and manufacturing of niche pharmaceutical products for the generic industry | $2.74M | 53/100 | ||
8th | Turnkey solutions for drug development, manufacturing and regulatory approvals | - | 52/100 | ||
9th | CDMO focused on amino acids and small molecules | - | - | 51/100 | |
10th | Aptuit 2004, Greenwich (United States), Acquired | Pioneering drug discovery and development, accelerating concept to cure | $14.2M | 50/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Concord Biotech's competitors? Click here to see the top ones
Concord Biotech's Latest cap tables and shareholding
Founders (largest shareholder) own 39.97%, Funds own 3.33%, Enterprises own 15.67% and Angels own 29.62%. The net worth of Concord Biotech's founders is INR 950Cr as of Jul 05, 2016.
Shareholders Name | Post Round Holding % | Net worth | Cumulative Investment | Realised Returns | Unrealised Returns | Return Multiple |
|---|---|---|---|---|---|---|
Founder | 39.97% | 950Cr | 2334877 | 8244490 | 8176257 | 7887972 |
1497168 | 4408064 | 3399126 | 3040515 | 7236625 | 7932303 | |
Fund | 3.33% | 79.1Cr | 186 | 831 | 775 | 938 |
339 | 614 | 911 | 936 | 952 | 396 | |
Enterprise | 15.67% | 373Cr | 7024399 | 4021661 | 3998927 | 7818524 |
Angel | 29.62% | 704Cr | 4889312 | 2488598 | 4883591 | 3142189 |
8858228 | 3977918 | 3105825 | 2925502 | 9633813 | 7143765 | |
Other Investors | 11.40% | 271Cr | 5762601 | 9886037 | 5350831 | 5327061 |
Total | 99.99% | 2,380Cr | 5069329 | 3532927 | 7393876 | 4634089 |
To unlock detailed Cap Table of Concord Biotech Sign up today!Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
DisclaimerView more details of Concord Biotech's Shareholding
Concord Biotech's Investments and acquisitions
Concord Biotech has a total of 1 investment in Palvella Therapeutics. Concord Biotech has not made any acquisitions as of now.Reports related to Concord Biotech
Here is the latest report on Concord Biotech's geography:
News related to Concord Biotech
Filter this listMedia has covered Concord Biotech for a total of 3 events in the last 1 year.
•
Concord Biotech shares rise 2% on USFDA nod for immunosuppressantMoneycontrol•Jun 03, 2026•Concord Biotech
•
•
Concord Biotech to Procure Wind-Solar Power from Clean Max’s ProjectMercom India•Jan 17, 2025•Concord Biotech, CleanMax
•
Concord Biotech invests USD 10 lakh in Palvella TherapeuticsNewsDrum•Dec 12, 2024•Palvella Therapeutics, Concord Biotech
•
Concord Biotech IPO to open on August 4; Here are key things to knowLivemint•Sep 03, 2024•Concord Biotech
•
•
Ontario Inc to sell 3.4% in Concord Biotech, deal size worth Rs 468.40 croreMoneycontrol•May 27, 2024•Concord Biotech
•
•
Concord Biotech IPO Sees Strong Demand: Subscribed 1.91 Times Overall On Day 2India Infoline•Aug 12, 2023•Concord Biotech, INDUSLAW, Gov.sg, ADIA and 15 others
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Concord Biotech
Explore our recently published companies
- Wisdom Square Technologies - New Hyde Park based, 2008 founded, Unfunded company
- Fruverpack - Almoradi based, 1992 founded, Unfunded company
- AERA - Bouxwiller based, 1979 founded, Unfunded company
- Divine Hindu - Ujjain based, 2023 founded, Unfunded company
- Globaldigitalpartner.com - 2013 founded, Unfunded company
- OROK - Bourgoin Jallieu based, 2018 founded, Deadpooled company
